This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abclonal Science, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Nicholas J DeBerardinis
Introduction
Nicholas J DeBerardinis is a notable inventor based in Melrose, MA (US). He has made significant contributions to the field of molecular biology, particularly in the development of DNA polymerase variants.
Latest Patents
Nicholas holds a patent for "Taq DNA polymerase variants with increased reverse transcriptase activity." This invention involves Taq DNA polymerase mutants that exhibit reverse transcriptase activity compared to the wild type polymerase. These mutants were engineered, characterized, and selected through polymerase chain reactions, which were visualized via electrophoresis on agarose gels. The initial screening was followed by probe-based qualitative, real-time PCR (qPCR) using a typical reverse transcription cycling protocol to detect specified ribonucleic acid (RNA) target sequences. The engineered variants can produce robust cDNA from RNA target substrates and amplify that cDNA under standard reaction conditions without the need for added reverse transcriptase enzymes. Nicholas has 1 patent to his name.
Career Highlights
Nicholas is currently employed at Abclonal Science, Inc., where he continues to innovate in the field of biotechnology. His work focuses on enhancing the capabilities of DNA polymerases, which are crucial for various applications in genetic research and diagnostics.
Collaborations
He has collaborated with notable colleagues such as Zhenyu Zhu and Dapeng Sun, contributing to advancements in their shared field of expertise.
Conclusion
Nicholas J DeBerardinis is a prominent figure in the realm of molecular biology, with a focus on improving DNA polymerase functionality. His innovative work continues to impact the scientific community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile